vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - cepiva - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 in 5. 1 in product information document). uporaba tega cepiva mora biti v skladu z uradnimi priporočili.
bimervax
hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - cepiva - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.
zoonotic influenza vaccine seqirus
seqirus s.r.l. - zoonotic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted), influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/turkey/turkey/1/05 (h5n1)-like strain (nibrg-23) - influenza a virus, h5n1 subtype - cepiva - active immunisation against h5 subtype of influenza a virus.
atifan 250 mg tablete
krka, d.d., novo mesto - terbinafin - tableta - terbinafin 250 mg / 1 tableta - terbinafin
atifan 125 mg tablete
krka, d.d., novo mesto - terbinafin - tableta - terbinafin 125 mg / 1 tableta - terbinafin
exoderil 10 mg/g krema
lek d.d. - niftifin - krema - niftifin 8,9 mg / 1 g - naftifin
exoderil 10 mg/g krema
lek d.d. - niftifin - krema - niftifin 8,9 mg / 1 g - naftifin
atifan 10 mg/g krema
krka, d.d., novo mesto - terbinafin - krema - terbinafin 8,89 mg / 1 g - terbinafin
lamisil 250 mg tablete
novartis pharma gmbh - terbinafin - tableta - terbinafin 250 mg / 1 tableta - terbinafin
lamisil 10 mg/g krema
glaxosmithkline dungarvan ltd - terbinafin - krema - terbinafin 8,8 mg / 1 g - terbinafin